GC33 (RO5137382)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GC33 (RO5137382), covering 2020-04-03 to 2020-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma [Phase 2]